When good drugs go bad

被引：0
|
作者：
Kathleen M. Giacomini
Ronald M. Krauss
Dan M. Roden
Michel Eichelbaum
Michael R. Hayden
Yusuke Nakamura
机构：
[1] University of California,Kathleen M. Giacomini is in the Department of Biopharmaceutical Sciences
[2] San Francisco,undefined
[3] Ronald M. Krauss is at the Childrens Hospital Oakland Research Institute,undefined
[4] Dan M. Roden is at the Vanderbilt University School of Medicine,undefined
[5] Michel Eichelbaum is at the Stuttgart Institut Klinische Pharmakologie,undefined
[6] Michael R. Hayden is at the University of British Columbia,undefined
[7] Yusuke Nakamura is at the University of Tokyo.,undefined
来源：
Nature | 2007年 / 446卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
How can we best reduce the risk of severe adverse reactions to marketed drugs? An international group of scientists argues that a global research network is needed to identify genetically at-risk populations.
引用
收藏
页码：975 / 977
页数：2
相关论文
共 50 条
12345